These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 541683)

  • 21. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccine.
    Lancet; 1980 Dec; 2(8206):1229-30. PubMed ID: 6108398
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B vaccination - before a breakthrough?].
    Grob PJ
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1146-53. PubMed ID: 7025194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active hepatitis B immunization with an experimental German vaccine. IV. Reactogenicity studies in healthy adults and in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):456-65. PubMed ID: 6485640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine against hepatitis B--18 months prevention in a high risk setting.
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P; Baudin S; Geslin N
    Med Microbiol Immunol; 1978 Nov; 166(1-4):109-18. PubMed ID: 723783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoprophylaxis of hepatitis B. 4. Identification of risk groups, recommendations for inoculation, new developments].
    Zoulek G; Jilg W; Deinhardt F
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1263-8. PubMed ID: 6224668
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
    Mahallawi W
    Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients.
    Sezer S; Ozdemir FN; Güz G; Arat Z; Colak T; Sengul S; Turan M; Haberal A; Erdal R
    Transplant Proc; 2000 May; 32(3):607-8. PubMed ID: 10812136
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune response in neonates to hepatitis B vaccine.
    Barin F; Goudeau A; Denis F; Yvonnet B; Chiron JP; Coursaget P; Mar ID
    Lancet; 1982 Jan; 1(8266):251-3. PubMed ID: 6120276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
    Feng Y; Shi X; Shi J; Gao L; Liu G; Cheng Y; Pan M; Li C; Wang J; Guo X; Zhang Y; Liang X; Wang S
    Expert Rev Vaccines; 2017 Oct; 16(10):1045-1052. PubMed ID: 28803502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis B vaccines: present and future (author's transl)].
    Thiry L
    Rev Med Brux; 1981 Jun; 2(6):535-42. PubMed ID: 7022601
    [No Abstract]   [Full Text] [Related]  

  • 33. Newly licensed hepatitis B vaccine. Known safety and unknown risks.
    Gerety RJ; Tabor E
    JAMA; 1983 Feb; 249(6):745-6. PubMed ID: 6337271
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Feb; 1(8218):455-9. PubMed ID: 6110088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus screening in a high-risk college population.
    Campos-Outcalt D
    J Am Coll Health; 1985 Dec; 34(3):120-2. PubMed ID: 4086715
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccine use in chronic hemodialysis centers in the United States.
    Alter MJ; Favero MS; Maynard JE
    JAMA; 1985 Dec; 254(22):3200-2. PubMed ID: 2933534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.